PATENT CLAIM ANALYSIS

Application Number: 15759723
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "085200"]

Abstract:
This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.

Claim (Index 56):
A method of preparing a population of cells comprising an adaptive NK cell, wherein the adaptive NK cell is CD3 \u2212 , CD56 +  and is at least one of CD57 + , NKG2C + , SYK \u2212 , Fc\u03b5R\u03b3 \u2212 , EAT-2 \u2212 , CD56 dim , TIGIT low , CD45RO + , and CD45RA \u2212 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12855203', '13865762', '13946266', '14547084', '15167166']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.673788096336552
- 35 USC 102 Novelty (BERT): 0.534797776212077
- Combined Prediction Score: 0.6598890643241045
- Mean Citation Score: 332.60156
- Max Citation Score: 374.96857
- Similarity Product: 231.5817375794768

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test